1 Hybrid Cell-gene Therapy for Pulmonary Hypertension Based on Phagocytosing Action of Endothelial Progenitor Cells(Plenary Session 8 (PL8) (IHD) : Toward Optimal Transplant Programs in Japan : from Cellular, Tissue and Solid Organ Aspects)(Special Program)

  • Mori Hidezo
    Department of Cardiac Physiology, National Cardiovascular Center Research Institute
  • Nagaya Noritoshi
    Department of Regenerative Medicine and Tissue Engineering, National Cardiovascular Center Research Instutute
  • Kangawa Kenji
    Department of Biochemistry, National Cardiovascular Center Research Instutute
  • Tabata Yasuhiko
    Department of Biomaterials, Field of Tissue Engineering, Institute for Frontier Medical Sciences, Kyoto University

この論文をさがす

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ